RxSight grants CEO new RSUs and stock options

RxSight, Inc. granted President and CEO Aziz Mottiwala 2,312,138 restricted stock units, each representing a contingent right to one share of Common Stock, and stock options for 571,286 shares at an exercise price of $5.19 per share.

Rhea-AI Filing Summary

RxSight, Inc. granted President and CEO Aziz Mottiwala 2,312,138 restricted stock units, each representing a contingent right to one share of Common Stock, and stock options for 571,286 shares at an exercise price of $5.19 per share. The RSUs and options vest over multi-year schedules contingent on continued service, with resulting direct holdings equal to the granted amounts.

Insider Trade Summary

Grant/Award: 2,883,424 shares

Grant/Award 2 txns

Insider Mottiwala Aziz

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1, F2	2,312,138	$0.00	$0.00
Grant/Award	Stock Option (right to buy) F3	571,286	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 2,312,138 contracts (Direct); Stock Option (right to buy) — 571,286 contracts (Direct)

Footnotes (3)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. F2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty percent (20%) of the RSUs subject to the award shall vest on the one year anniversary of the grant date, twenty percent (20%) of the RSUs subject to the award shall vest on the two year anniversary of the grant date, and 60% of the RSUs subject to the award shall vest on the three year anniversary of the grant date.
3. F3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and, thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 24, 2026.

Key Figures

RSU award: 2,312,138 restricted stock units Stock options granted: 571,286 options Option exercise price: $5.19 per share +3 more

6 metrics

RSU award 2,312,138 restricted stock units Granted to President and CEO Aziz Mottiwala on 2026-07-24

Stock options granted 571,286 options Options to purchase Common Stock granted on 2026-07-24

Option exercise price $5.19 per share Exercise price for 571,286 stock options granted to the CEO

Option expiration date 2036-07-23 Expiration date of the CEO’s 571,286 stock options

RSU vesting schedule 20% / 20% / 60% RSUs vest on the first, second, and third anniversaries of the grant date, subject to service

Option vesting schedule 25% after 1 year; 1/48 monthly Vests based on the Vesting Commencement Date of July 24, 2026, with continued service required

Key Terms

Restricted Stock Unit, Inducement Equity Incentive Plan, Vesting Commencement Date, Stock Option (right to buy)

4 terms

Restricted Stock Unit financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Inducement Equity Incentive Plan financial

"as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date"

An inducement equity incentive plan is a program that grants employees or executives company shares or stock options to motivate and reward their work, often as a way to attract new talent. It aligns their interests with the company's success, encouraging them to contribute to long-term growth. For investors, such plans can influence a company's stock performance and overall financial health by motivating key personnel.

Vesting Commencement Date financial

""Vesting Commencement Date" shall mean July 24, 2026."

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

Stock Option (right to buy) financial

"Stock Option (right to buy) with an exercise price of 5.1900 per share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did RxSight (RXST) grant to CEO Aziz Mottiwala in this Form 4?

RxSight granted CEO Aziz Mottiwala 2,312,138 restricted stock units and stock options for 571,286 shares of Common Stock. The options carry a $5.19 per share exercise price and both awards vest over time, conditioned on his continued service as a Service Provider.

How do the 2,312,138 RSUs granted to the RxSight (RXST) CEO vest?

The 2,312,138 RSUs vest in three tranches: 20% on the first anniversary of the grant date, another 20% on the second anniversary, and the remaining 60% on the third anniversary, all subject to Aziz Mottiwala continuing as a Service Provider.

What are the key terms of the 571,286 stock options reported for RxSight (RXST)?

The filing reports 571,286 stock options with an exercise price of $5.19 per share, expiring on 2036-07-23. Vesting is 25% on the one-year anniversary of the Vesting Commencement Date, then 1/48 of the shares vest monthly, subject to continued service.

Are the RxSight (RXST) CEO’s reported RSU and option holdings direct or indirect?

Both the 2,312,138 RSUs and 571,286 stock options are reported as direct holdings. The ownership code is "D" for each transaction, and there is no footnote indicating that the awards are held through a separate entity or trust.

What plan governs the new equity awards to the RxSight (RXST) CEO?

The vesting of both the RSUs and the stock options is conditioned on continued service as defined in RxSight’s 2026 Inducement Equity Incentive Plan. The plan’s terms determine who qualifies as a Service Provider for vesting to continue.

What does each restricted stock unit represent in the RxSight (RXST) CEO’s award?

Each RSU granted to Aziz Mottiwala represents a contingent right to receive one share of RxSight’s Common Stock. Delivery of the underlying shares occurs as the RSUs vest under the three-year schedule and the service conditions are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/24/2026 - 08:08 PM Accepted by SEC EDGAR 07/24/2026 - 08:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mottiwala Aziz

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	07/24/2026		A		2,312,138		(2)	(2)	Common Stock	2,312,138	$0	2,312,138	D
Stock Option (right to buy)	$5.19	07/24/2026		A		571,286		(3)	07/23/2036	Common Stock	571,286	$0	571,286	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty percent (20%) of the RSUs subject to the award shall vest on the one year anniversary of the grant date, twenty percent (20%) of the RSUs subject to the award shall vest on the two year anniversary of the grant date, and 60% of the RSUs subject to the award shall vest on the three year anniversary of the grant date.

3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and, thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 24, 2026.

	/s/ Jim Schindler, as Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)